Pacific Biosciences of California, Inc. (PACB)
-NasdaqGS | Prev Close: | 2.79 |
|---|
| Open: | N/A |
|---|
| Bid: | 2.62 x 600 |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 2.63 |
|---|
| Beta: | 4.14 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 1.06 - 3.25 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 386,402 |
|---|
| Market Cap: | 169.70M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.56 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 High Growth Healthcare Stocks With Heavy Insider Buyingat TheStreet(Tue, Jun 18)
- 2 Stocks to Buy, 1 to Holdat Motley Fool(Thu, Jun 6)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission ofEDGAR Online(Wed, May 22)
- Insiders And Funds Are Bullish On These 3 Small Cap Healthcare Stocksat Seeking Alpha(Tue, May 21)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. FinancialsEDGAR Online Financials(Fri, May 17)
- Pacific Biosciences and Sage Science Announce Co-Marketing PartnershipGlobeNewswire(Thu, May 16)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- New Assembly Method Published for Rapid and Automated Genome Sequencing Using Long-Read, Single Molecule, Real-Time (SMRT(R)) SequencingGlobeNewswire(Mon, May 6)
- Is Illumina's Stock Destined for Greatness?at Motley Fool(Tue, Apr 30)
- 5 Stocks Burning Their Shortsat Motley Fool(Tue, Apr 30)
- 3 Biotechs Flying Under The Radarat Seeking Alpha(Tue, Apr 30)
- Pacific Biosciences of California Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 23)
- Pacific Biosciences of California Earnings: Here’s Why Investors are Excited Nowat Wall St. Cheat Sheet(Tue, Apr 23)
- Pacific Biosciences of California, Inc. Announces First Quarter 2013 Financial ResultsGlobeNewswire(Tue, Apr 23)
- Four Lessons From IBM And Roche's Failed DNA Collaborationat Forbes(Tue, Apr 23)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 7.88 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.37 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.36 |
|---|
| Mean Recommendation*: | 3.4 |
|---|
| PEG Ratio (5 yr expected): | -0.07 |
|---|
Business Summary
Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis. The company engages in developing a single molecule, real-time, (SMRT) technology for the detection of biological processes.
View More 
1.35%